Cetera Investment Advisers
TMDX icon

Cetera Investment Advisers’s Transmedics TMDX Stock Holding History

Cetera Investment Advisers’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Sell
10,542
-6,531
-38% -$553K ﹤0.01% 3380
2026
Q1 		$1.7M Buy
17,073
+6,302
+59% +$822K ﹤0.01% 2439
2025
Q4 		$1.31M Buy
10,771
+2,240
+26% +$281K ﹤0.01% 2597
2025
Q3 		$957K Buy
8,531
+2,206
+35% +$258K ﹤0.01% 2798
2025
Q2 		$848K Buy
6,325
+2,292
+57% +$252K ﹤0.01% 2522
2025
Q1 		$271K Sell
4,033
-4,227
-51% -$291K ﹤0.01% 3348
2024
Q4 		$515K Buy
8,260
+634
+8% +$59K ﹤0.01% 2655
2024
Q3 		$1.2M Sell
7,626
-1,079
-12% -$166K ﹤0.01% 1997
2024
Q2 		$1.31M Sell
8,705
-2,401
-22% -$288K ﹤0.01% 1872
2024
Q1 		$821K Buy
11,106
+2,603
+31% +$215K ﹤0.01% 2229
2023
Q4 		$671K Buy
8,503
+918
+12% +$55.4K 0.01% 1331
2023
Q3 		$415K Buy
7,585
+235
+3% +$16.9K ﹤0.01% 1526
2023
Q2 		$617K Buy
7,350
+196
+3% +$15K 0.01% 1326
2023
Q1 		$542K Sell
7,154
-1,895
-21% -$131K ﹤0.01% 1382
2022
Q4 		$559K Buy
9,049
+1,658
+22% +$88.1K 0.01% 1316
2022
Q3 		$309K Sell
7,391
-2,743
-27% -$119K 0.01% 1249
2022
Q2 		$319K Buy
10,134
+26
+0.3% +$693 0.01% 1378
2022
Q1 		$272K Sell
10,108
-1,292
-11% -$23.1K ﹤0.01% 1536
2021
Q4 		$218K Buy
11,400
+724
+7% +$18.1K ﹤0.01% 1682
2021
Q3 		$353K Buy
10,676
+287
+3% +$8.77K 0.01% 1330
2021
Q2 		$345K Buy
10,389
+4,482
+76% +$124K 0.01% 1329
2021
Q1 		$245K Buy
+5,907
New +$182K ﹤0.01% 1360

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Cetera Investment Advisers's TMDX Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Transmedics (TMDX) stake by 38% in Q2 2026, selling an estimated $553K and leaving 10,542 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #3380.

Cetera Investment Advisers first reported a position in TMDX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.7M in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Cetera Investment Advisers held 10,542 shares of Transmedics worth $700K as of Q2 2026.
  • Cetera Investment Advisers sold 6,531 Transmedics shares in Q2 2026, an estimated $553K.
  • Transmedics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3380 holding.
  • Cetera Investment Advisers first reported a position in Transmedics in Q1 2021 and has held it in 22 quarters since.
  • Cetera Investment Advisers's Transmedics position peaked at $1.7M in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.